Article(id=1329527593088430654, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527576395100605, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.11.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1722528000000, receivedDateStr=2024-08-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913679619, onlineDateStr=2026-11-17, pubDate=1731168000000, pubDateStr=2024-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913679619, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913679619, creator=13701087609, updateTime=1794913679619, updator=13701087609, issue=Issue{id=1329527576395100605, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='11', pageStart='1105', pageEnd='1211', issueExtLink='null', onlineDate='null', pubDate='1731168000000', pubDateStr='2024-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913675640, creator='13701087609', updateTime=1794962226160, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329731212412825960, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527576395100605, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329731212412825961, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527576395100605, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1117, endPage=1124, ext={EN=ArticleExt(id=1329527593319117375, articleId=1329527593088430654, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Assessment of drug availability and policy optimization for rare disease in China, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=
Objective

To evaluate the availability of drugs for rare disease treatment in China and to provide suggestions for optimizing the supply system for the treatment of rare diseases in China.

Methods

The current status of rare disease drugs in China was analyzed by accessing databases and literature, and the availability rate of these drugs in tertiary hospitals and the national collaborative network of hospitals for rare disease diagnosis and treatment was evaluated by using the World Health Organization/Health Action International standard survey method.

Results

There were only 176 drugs in the two batches of rare disease catalogs, and 54% of those diseases had no drugs. The average preparation rate of 47 negotiated rare disease drugs in tertiary hospitals and hospitals of rare disease diagnosis and treatment collaborative network in the agreement period of the 2023 medical insurance catalog was only 6% and 14%, respectively.

Conclusion

The low availability of rare disease drugs in China is mainly due to the lack of research and development motivation of pharmaceutical companies and the high cost of drug management in hospitals. It is recommended to optimize the identification criteria of the catalog and preferential policies to strengthen the guiding effect of the catalog on the therapeutic areas. And to give priority to the special policy inclination of the whole process of super-rare disease drugs to guide their research and development to the market. Meanwhile, to issue the list of drug innovations for rare diseases and set up a centralized pharmacy to establish a supply system centered on the collaborative network hospitals.

, authors=Rui LU1, Ye CHEN1, 2, Jixi DING1, 2, *, authorsList=Rui LU, Ye CHEN, Jixi DING, authorCompany=null, correspAuthors=Jixi DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527593591747136, articleId=1329527593088430654, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=中国罕见病治疗药物可获得性评估与政策优化, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=
目的

评估中国罕见病治疗药物的可获得性,为优化国家罕见病治疗药物供给制度提供建议。

方法

通过访问数据库和梳理相关文献中国罕见病用药上市现状,使用世界卫生组织/国际健康行动机构标准调查法评估该类药物在三级医院和罕见病诊疗协作网医院的配备率。

结果

两批罕见病目录内疾病上市治疗药物仅176种,目录内54%的疾病“无药可治”;2023年医保目录协议期内47种谈判罕见病用药在三级医院和罕见病诊疗协作网医院的平均配备率分别仅为6%和14%。

结论

中国罕见病用药可获得性较低,原因主要为药企研发动力不足、医院用药管理成本高不愿配备等。建议优化目录认定标准及优惠政策认定标准,强化目录对治疗领域的引导作用;优先给予超级罕见病用药全流程特殊的政策倾斜,引导其研发上市;出台罕见病药物创新清单并建立中心药库,建立以协作网医院为中心的配备供应体系。

, authors=鲁瑞1, 陈烨1, 2, 丁锦希1, 2, *, authorsList=鲁瑞, 陈烨, 丁锦希, authorCompany=null, correspAuthors=丁锦希, authorNote=

鲁瑞,硕士研究生,研究方向:社会与管理药学。

, correspAuthorsNote=
丁锦希,二级教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=QXW8d+Em5rRfsiRYvOt74g==, magXml=ROeR/jIMRJB21Rgi+t8qIw==, pdfUrl=null, pdf=akH9y+FC9JNyNQ52LRN9Tg==, pdfFileSize=1631821, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=fu94sPswbAXe2fVRG1Vnmw==, mapNumber=null, fund=null)}, authors=[Author(id=1329532778296750387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532778372247861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778296750387, language=EN, stringName=Rui LU, firstName=Rui, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532778447745334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778296750387, language=CN, stringName=鲁瑞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio={"content":"

鲁瑞,硕士研究生,研究方向:社会与管理药学。

"}, bioImg=null, bioContent=

鲁瑞,硕士研究生,研究方向:社会与管理药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1329532778523242808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532778602934587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778523242808, language=EN, stringName=Ye CHEN, firstName=Ye, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532778661654844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778523242808, language=CN, stringName=陈烨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532778225447215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=2., ext=[AuthorCompanyExt(id=1329532778233835824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778242224433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1329532778724569406, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329532778812649793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778724569406, language=EN, stringName=Jixi DING, firstName=Jixi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532778892341570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778724569406, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532778225447215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=2., ext=[AuthorCompanyExt(id=1329532778233835824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778242224433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])], keywords=[Keyword(id=1329532779051725123, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, language=EN, orderNo=1, keyword=rare disease catalog), Keyword(id=1329532779118833988, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, language=EN, orderNo=2, keyword=national basic medical insurance), Keyword(id=1329532779185942853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, language=EN, orderNo=3, keyword=availability), Keyword(id=1329532779257246022, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, language=CN, orderNo=1, keyword=罕见病目录), Keyword(id=1329532779320160583, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, language=CN, orderNo=2, keyword=国家基本医疗保险), Keyword(id=1329532779387269448, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, language=CN, orderNo=3, keyword=可获得性)], refs=[Reference(id=1329532779563430217, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=沙利文病痛挑战基金会. 2024中国罕见病行业趋势观察报告[R]. 北京: 沙利文病痛挑战基金会., articleTitle=null, refAbstract=null), Reference(id=1329532779634733386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 关于公布第一批罕见病目录的通知[国卫医发(2018)10号][EB/OL]. (2018-12-31) [2024-06-25]. https://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435167.htm., articleTitle=null, refAbstract=null), Reference(id=1329532779710230859, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 关于公布第二批罕见病目录的通知[国卫医政发(2023)26号][EB/OL]. (2023-09-18) [2024-06-25]. https://www.gov.cn/zhengce/zhengceku/202309/content_6905273.htm., articleTitle=null, refAbstract=null), Reference(id=1329532779777339724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Chiu ATG, Chung CCY, Wong WHS, et al. Healthcare burden of rare diseases in Hong Kong – adopting ORPHAcodes in ICD-10 based healthcare administrative datasets[J]. Orphanet J Rare Dis, 2018, 13: 1, articleTitle=null, refAbstract=null), Reference(id=1329532779844448589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Wold Health Organization. Medicine prices: a new approach to measurement. Working draft for field-testing and revision[EB/OL]. [2010-03-01]. http://www.haiweb.org/medicineprices/manual/manuals/MedicinePrices.pdf., articleTitle=null, refAbstract=null), Reference(id=1329532779915751758, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries[J]. Bull World Health Organ, 2007, 85(4): 279-288., articleTitle=null, refAbstract=null), Reference(id=1329532779974472015, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=刘清扬, 刘鑫, 左玮, 等. 基于《第二批罕见病目录》的罕见病药物目录和药物可及性研究[J]. 罕见病研究, 2024, 3(2): 195-201., articleTitle=null, refAbstract=null), Reference(id=1329532781622833488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=刘清扬, 刘鑫, 王少红, 等. 基于《第一批罕见病目录》的罕见病药物可及性研究[J]. 协和医学杂志, 2023, 14(6): 1208-1216., articleTitle=null, refAbstract=null), Reference(id=1329532781706719569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=王少红, 刘鑫, 刘清扬, 等. 2023年度中国、美国、欧盟、日本批准上市罕见病用药概览与分析[J]. 罕见病研究, 2024, 3(2): 202-213., articleTitle=null, refAbstract=null), Reference(id=1329532781778022738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=药智网. 2024上半年FDA批准的新药[EB/OL]. (2024-06-24) [2024-06-29]. https://m.baidu.com/bh/m/detail/ar_9263044838693679203., articleTitle=null, refAbstract=null), Reference(id=1329532781866103123, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=严慧芳. “超级罕见病”支付困境如何破题?[N]. 南方日报, 2022-03-04(B03). DOI: 10.28597/n.cnki.nnfrb.2022.001201., articleTitle=null, refAbstract=null), Reference(id=1329532781941600596, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=国家统计局. 2023年居民收入和消费支出情况[EB/OL]. (2024-01-17) [2024-08-02]. https://www.stats.gov.cn/sj/zxfb/202401/t20240116_1946622.html., articleTitle=null, refAbstract=null), Reference(id=1329532782012903765, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=彭美华, 王科又, 钟晨, 等. 我国罕见病医疗保障制度优化路径研究——基于疾病负担公平视角[J]. 保险职业学院学报, 2023, 37(2): 65-70., articleTitle=null, refAbstract=null), Reference(id=1329532782096789846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=中华人民共和国国家卫生健康委员会. 罕见病诊疗指南(2019年版)[EB/OL]. (2019-02-07) [2024-08-02]. http://www.nhc.gov.cn/yzygj/s7659/201902/61d06b4916c348e0810ce1fceb844333/files/e2113203d0bf45d181168d855426ca7c.pdf., articleTitle=null, refAbstract=null), Reference(id=1329532782163898711, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Nowicki M, Bazan-Socha S, Blazejewska-Hyzorek B, et al. Enzyme replacement therapy in Fabry disease in Poland: a position statement[J]. Pol Arch Intern Med, 2020, 130(1): 91-97., articleTitle=null, refAbstract=null), Reference(id=1329532782251979096, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会血液学分会红细胞疾病(贫血)学组. 中国成人戈谢病诊治专家共识(2020)[J]. 中华医学杂志, 2020, 100(24): 1841-1849., articleTitle=null, refAbstract=null), Reference(id=1329532782344253785, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会心血管病学分会动脉粥样硬化及冠心病学组, 中华心血管病杂志编辑委员会. 家族性高胆固醇血症筛查与诊治中国专家共识[J]. 中华心血管病杂志, 2018, 46(2): 99-103., articleTitle=null, refAbstract=null), Reference(id=1329532782419751258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=张安安, 刘晓琴, 吴涛. 尼曼匹克病C型诊治进展[J]. 国际遗传学杂志志, 2023, 46(3): 216-222., articleTitle=null, refAbstract=null), Reference(id=1329532782503637339, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=殷德厚, 刘长林, 赵秀兰, 等. 牡丹江地区五县(市)十年阵发性睡眠性血红蛋白尿症的流行病学调查[J]. 中华血液学杂志, 1989, 10(12): 631-633., articleTitle=null, refAbstract=null), Reference(id=1329532782566551900, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=罕见病信息网. 豆固醇血症[EB/OL]. (2024-03-04) [2024-08-02]. https://raredisease.cn/Encyclopedia/Info/21875., articleTitle=null, refAbstract=null), Reference(id=1329532782637855069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=孙焕霞, 苏厚恒, 石颜军. 系统性硬化病发病机制探讨及展望[J]. 中华风湿病学杂志, 2020, 24(7): 491-495., articleTitle=null, refAbstract=null), Reference(id=1329532782704963934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=童凡, 杨茹莱, 刘畅, 等. 新生儿酪氨酸血症筛查及基因谱分析[J]. 浙江大学学报(医学版), 2019, 48(4): 459-464., articleTitle=null, refAbstract=null), Reference(id=1329532782780461407, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=EvansDG, HusonSM, DonnaiD, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. Ⅰ. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity[J]. J Med Genet, 1992, 29(12): 841-846., articleTitle=null, refAbstract=null), Reference(id=1329532782851764576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=EvansDG. Neurofibromatosis type 2 (NF2): a clinical and molecular review[J]. Orphanet J Rare Dis, 2009, 4: 16., articleTitle=null, refAbstract=null), Reference(id=1329532782918873441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Isayama H, Tazuma S, Kokudo N, et al. Clinical guidelines for primary sclerosing cholangitis 2017[J]. J Gastroenterol, 2018, 53(9): 1006-1034., articleTitle=null, refAbstract=null), Reference(id=1329532782985982306, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Ang TL, Fock KM, Ng TM, et al. Clinical profile of primary sclerosing cholangitis in Singapore[J]. J Gastroenterol Hepatol, 2002, 17(8): 908-913., articleTitle=null, refAbstract=null), Reference(id=1329532783053091171, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=International Waldenstrom's Macroglobulinemia Foundation[EB/OL]. (2021-12-03) [2024-08-02]. https://iwmf.com/wp-content/uploads/2020/10/TargetedTherapies-PathwayInhibitors-CHINESESIMPLIFIED.pdf., articleTitle=null, refAbstract=null), Reference(id=1329532783174725988, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=房云海, 王杰, 王惜媛, 等. 血管性血友病: 千里挑一还是万里挑一[J]. 血栓与止血学, 2024, 30(3): 95-98., articleTitle=null, refAbstract=null), Reference(id=1329532783254417765, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药监局药审中心. 国家药监局药审中心关于发布《罕见病酶替代疗法药物非临床研究指导原则(试行)》的通告(2024年第17号)[EB/OL]. (2024-02-23) [2024-08-02]. https://www.cde.org.cn/main/news/viewInfoCommon/ae3f90280fab5c58f928728816ede70c., articleTitle=null, refAbstract=null), Reference(id=1329532783325720934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=翟取, 苗采烈, 汤涵, 等. 我国零售药店执业药师药学服务能力自我评价调查研究[J]. 中国食品药品监管, 2024, (1): 98-108., articleTitle=null, refAbstract=null), Reference(id=1329532783409607015, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=国家医保局官方公众号. “国谈药”配备机构查询[EB/OL]. (2023-09-07) [2024-08-02]. https://wx.nhsa.gov.cn/?code=081VNe000lnrRS19wa100US3pZ0VNe0j&state=weichat#/pages/negotiatingDrugs/negotiatingDrugs., articleTitle=null, refAbstract=null), Reference(id=1329532783518658920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=何阿妹, 徐源, 宋捷, 等. 国家医保谈判药物中罕见病用药落地情况分析——以20种罕见病用药为例[J]. 中国医疗保险, 2023, (9): 18-26., articleTitle=null, refAbstract=null), Reference(id=1329532783594156393, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 关于印发罕见病目录制订工作程序的通知[EB/OL]. (2018-06-05) [2024-06-25]. http://www.nhc.gov.cn/yzygj/s7659/201806/927defed71934ec8b032ccfca0afe0fb.shtml., articleTitle=null, refAbstract=null), Reference(id=1329532783657070954, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=刘小龙, 练东玲, 吴健. 进行性骨化性纤维发育不良1例报告[J]. 中国实用内科杂志, 2021, 41(3): 261-264., articleTitle=null, refAbstract=null), Reference(id=1329532783732568427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=包和婧, 朱立新, 杨联军, 等. 我国进行性骨化性肌炎104例文献分析[J]. 分子影像学杂志, 2015, 38(4): 365-368., articleTitle=null, refAbstract=null), Reference(id=1329532783833231724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=张皖晋, 卓阳, 孙搏. 欧美罕见病药物研发的监管机制分析及启示[J]. 中国新药与临床杂志, 2023, 42(2): 85-90., articleTitle=null, refAbstract=null), Reference(id=1329532783925506413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 关于罕见病药品增值税政策的通知[财税(2019)24号][EB/OL]. (2019-10-15) [2024-06-28]. https://www.gov.cn/zhengce/zhengceku/2019-10/15/content_5439874.htm., articleTitle=null, refAbstract=null), Reference(id=1329532784009392494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=中国政府网. 国务院关税税则委员会决定调整进境物品进口税[EB/OL]. (2019-04-08) [2024-09-18]. https://www.gov.cn/xinwen/2019-04/08/content_5380553.htm., articleTitle=null, refAbstract=null), Reference(id=1329532784076501359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=陈昕, 熊潇磊, 龚时薇. 中美政府资助罕见病与罕用药科研基金项目的比较分析[J]. 中国医院药学杂志, 2016, 36(12): 961-963., articleTitle=null, refAbstract=null), Reference(id=1329532784143610224, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Boat T F, Field M J. Rare diseases and orphan products: accelerating research and development[M]. Washington Dc: National Academies Press, 2011., articleTitle=null, refAbstract=null), Reference(id=1329532784210719089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=张抒扬, 董咚. 2020中国罕见病综合社会调研[R]. 中国罕见病联盟: 北京., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532778225447215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=2., ext=[AuthorCompanyExt(id=1329532778233835824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778242224433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.11.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.11.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.11.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.11.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1731168000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
中国罕见病治疗药物可获得性评估与政策优化
鲁瑞 1 , 陈烨 1, 2 , 丁锦希 1, 2, *
世界临床药物 | 医药专论 2024,45(11): 1117-1124
收起
收藏切换
世界临床药物 |医药专论 2024 , 45 (11) : 1117 -1124
中国罕见病治疗药物可获得性评估与政策优化
全屏
[Author(id=1329532778296750387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532778372247861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778296750387, language=EN, stringName=Rui LU, firstName=Rui, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532778447745334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778296750387, language=CN, stringName=鲁瑞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国药科大学国际医药商学院,江苏 南京 211198, bio={"content":"

鲁瑞,硕士研究生,研究方向:社会与管理药学。

"}, bioImg=null, bioContent=

鲁瑞,硕士研究生,研究方向:社会与管理药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)])]), Author(id=1329532778523242808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329532778602934587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778523242808, language=EN, stringName=Ye CHEN, firstName=Ye, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532778661654844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778523242808, language=CN, stringName=陈烨, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532778225447215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=2., ext=[AuthorCompanyExt(id=1329532778233835824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778242224433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])]), Author(id=1329532778724569406, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329532778812649793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778724569406, language=EN, stringName=Jixi DING, firstName=Jixi, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329532778892341570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, authorId=1329532778724569406, language=CN, stringName=丁锦希, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国药科大学国际医药商学院,江苏 南京 211198
2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329532778154144044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=1., ext=[AuthorCompanyExt(id=1329532778162532653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778166726958, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778154144044, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国药科大学国际医药商学院,江苏 南京 211198)]), AuthorCompany(id=1329532778225447215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, xref=2., ext=[AuthorCompanyExt(id=1329532778233835824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China), AuthorCompanyExt(id=1329532778242224433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527593088430654, companyId=1329532778225447215, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198)])])]
鲁瑞1, 陈烨1, 2, 丁锦希1, 2, *
作者信息
  • 1.中国药科大学国际医药商学院,江苏 南京 211198
  • 2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198
通讯作者:
丁锦希,二级教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
作者简介:

鲁瑞,硕士研究生,研究方向:社会与管理药学。

Assessment of drug availability and policy optimization for rare disease in China
Rui LU1, Ye CHEN1, 2, Jixi DING1, 2, *
Affiliations
  • 1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
  • 2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
出版时间: 2024-11-10 doi: 10.13683/j.wph.2024.11.002
文章导航
收藏切换
目的

评估中国罕见病治疗药物的可获得性,为优化国家罕见病治疗药物供给制度提供建议。

方法

通过访问数据库和梳理相关文献中国罕见病用药上市现状,使用世界卫生组织/国际健康行动机构标准调查法评估该类药物在三级医院和罕见病诊疗协作网医院的配备率。

结果

两批罕见病目录内疾病上市治疗药物仅176种,目录内54%的疾病“无药可治”;2023年医保目录协议期内47种谈判罕见病用药在三级医院和罕见病诊疗协作网医院的平均配备率分别仅为6%和14%。

结论

中国罕见病用药可获得性较低,原因主要为药企研发动力不足、医院用药管理成本高不愿配备等。建议优化目录认定标准及优惠政策认定标准,强化目录对治疗领域的引导作用;优先给予超级罕见病用药全流程特殊的政策倾斜,引导其研发上市;出台罕见病药物创新清单并建立中心药库,建立以协作网医院为中心的配备供应体系。

罕见病目录  /  国家基本医疗保险  /  可获得性
Objective

To evaluate the availability of drugs for rare disease treatment in China and to provide suggestions for optimizing the supply system for the treatment of rare diseases in China.

Methods

The current status of rare disease drugs in China was analyzed by accessing databases and literature, and the availability rate of these drugs in tertiary hospitals and the national collaborative network of hospitals for rare disease diagnosis and treatment was evaluated by using the World Health Organization/Health Action International standard survey method.

Results

There were only 176 drugs in the two batches of rare disease catalogs, and 54% of those diseases had no drugs. The average preparation rate of 47 negotiated rare disease drugs in tertiary hospitals and hospitals of rare disease diagnosis and treatment collaborative network in the agreement period of the 2023 medical insurance catalog was only 6% and 14%, respectively.

Conclusion

The low availability of rare disease drugs in China is mainly due to the lack of research and development motivation of pharmaceutical companies and the high cost of drug management in hospitals. It is recommended to optimize the identification criteria of the catalog and preferential policies to strengthen the guiding effect of the catalog on the therapeutic areas. And to give priority to the special policy inclination of the whole process of super-rare disease drugs to guide their research and development to the market. Meanwhile, to issue the list of drug innovations for rare diseases and set up a centralized pharmacy to establish a supply system centered on the collaborative network hospitals.

rare disease catalog  /  national basic medical insurance  /  availability
鲁瑞, 陈烨, 丁锦希. 中国罕见病治疗药物可获得性评估与政策优化. 世界临床药物, 2024 , 45 (11) : 1117 -1124 . DOI: 10.13683/j.wph.2024.11.002
Rui LU, Ye CHEN, Jixi DING. Assessment of drug availability and policy optimization for rare disease in China[J]. World Clinical Drug, 2024 , 45 (11) : 1117 -1124 . DOI: 10.13683/j.wph.2024.11.002

参考文献 引证文献
排序方式:
[1]
沙利文病痛挑战基金会. 2024中国罕见病行业趋势观察报告[R]. 北京: 沙利文病痛挑战基金会.
[2]
中国政府网. 关于公布第一批罕见病目录的通知[国卫医发(2018)10号][EB/OL]. (2018-12-31) [2024-06-25]. https://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435167.htm.
[3]
中国政府网. 关于公布第二批罕见病目录的通知[国卫医政发(2023)26号][EB/OL]. (2023-09-18) [2024-06-25]. https://www.gov.cn/zhengce/zhengceku/202309/content_6905273.htm.
[4]
Chiu ATG, Chung CCY, Wong WHS, et al. Healthcare burden of rare diseases in Hong Kong – adopting ORPHAcodes in ICD-10 based healthcare administrative datasets[J]. Orphanet J Rare Dis, 2018, 13: 1
[5]
Wold Health Organization. Medicine prices: a new approach to measurement. Working draft for field-testing and revision[EB/OL]. [2010-03-01]. http://www.haiweb.org/medicineprices/manual/manuals/MedicinePrices.pdf.
[6]
Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries[J]. Bull World Health Organ, 2007, 85(4): 279-288.
[7]
刘清扬, 刘鑫, 左玮, 等. 基于《第二批罕见病目录》的罕见病药物目录和药物可及性研究[J]. 罕见病研究, 2024, 3(2): 195-201.
[8]
刘清扬, 刘鑫, 王少红, 等. 基于《第一批罕见病目录》的罕见病药物可及性研究[J]. 协和医学杂志, 2023, 14(6): 1208-1216.
[9]
王少红, 刘鑫, 刘清扬, 等. 2023年度中国、美国、欧盟、日本批准上市罕见病用药概览与分析[J]. 罕见病研究, 2024, 3(2): 202-213.
[10]
药智网. 2024上半年FDA批准的新药[EB/OL]. (2024-06-24) [2024-06-29]. https://m.baidu.com/bh/m/detail/ar_9263044838693679203.
[11]
严慧芳. “超级罕见病”支付困境如何破题?[N]. 南方日报, 2022-03-04(B03). DOI: 10.28597/n.cnki.nnfrb.2022.001201.
[12]
国家统计局. 2023年居民收入和消费支出情况[EB/OL]. (2024-01-17) [2024-08-02]. https://www.stats.gov.cn/sj/zxfb/202401/t20240116_1946622.html.
[13]
彭美华, 王科又, 钟晨, 等. 我国罕见病医疗保障制度优化路径研究——基于疾病负担公平视角[J]. 保险职业学院学报, 2023, 37(2): 65-70.
[14]
中华人民共和国国家卫生健康委员会. 罕见病诊疗指南(2019年版)[EB/OL]. (2019-02-07) [2024-08-02]. http://www.nhc.gov.cn/yzygj/s7659/201902/61d06b4916c348e0810ce1fceb844333/files/e2113203d0bf45d181168d855426ca7c.pdf.
[15]
Nowicki M, Bazan-Socha S, Blazejewska-Hyzorek B, et al. Enzyme replacement therapy in Fabry disease in Poland: a position statement[J]. Pol Arch Intern Med, 2020, 130(1): 91-97.
[16]
中华医学会血液学分会红细胞疾病(贫血)学组. 中国成人戈谢病诊治专家共识(2020)[J]. 中华医学杂志, 2020, 100(24): 1841-1849.
[17]
中华医学会心血管病学分会动脉粥样硬化及冠心病学组, 中华心血管病杂志编辑委员会. 家族性高胆固醇血症筛查与诊治中国专家共识[J]. 中华心血管病杂志, 2018, 46(2): 99-103.
[18]
张安安, 刘晓琴, 吴涛. 尼曼匹克病C型诊治进展[J]. 国际遗传学杂志志, 2023, 46(3): 216-222.
[19]
殷德厚, 刘长林, 赵秀兰, 等. 牡丹江地区五县(市)十年阵发性睡眠性血红蛋白尿症的流行病学调查[J]. 中华血液学杂志, 1989, 10(12): 631-633.
[20]
罕见病信息网. 豆固醇血症[EB/OL]. (2024-03-04) [2024-08-02]. https://raredisease.cn/Encyclopedia/Info/21875.
[21]
孙焕霞, 苏厚恒, 石颜军. 系统性硬化病发病机制探讨及展望[J]. 中华风湿病学杂志, 2020, 24(7): 491-495.
[22]
童凡, 杨茹莱, 刘畅, 等. 新生儿酪氨酸血症筛查及基因谱分析[J]. 浙江大学学报(医学版), 2019, 48(4): 459-464.
[23]
EvansDG, HusonSM, DonnaiD, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. Ⅰ. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity[J]. J Med Genet, 1992, 29(12): 841-846.
[24]
EvansDG. Neurofibromatosis type 2 (NF2): a clinical and molecular review[J]. Orphanet J Rare Dis, 2009, 4: 16.
[25]
Isayama H, Tazuma S, Kokudo N, et al. Clinical guidelines for primary sclerosing cholangitis 2017[J]. J Gastroenterol, 2018, 53(9): 1006-1034.
[26]
Ang TL, Fock KM, Ng TM, et al. Clinical profile of primary sclerosing cholangitis in Singapore[J]. J Gastroenterol Hepatol, 2002, 17(8): 908-913.
[27]
International Waldenstrom's Macroglobulinemia Foundation[EB/OL]. (2021-12-03) [2024-08-02]. https://iwmf.com/wp-content/uploads/2020/10/TargetedTherapies-PathwayInhibitors-CHINESESIMPLIFIED.pdf.
[28]
房云海, 王杰, 王惜媛, 等. 血管性血友病: 千里挑一还是万里挑一[J]. 血栓与止血学, 2024, 30(3): 95-98.
[29]
国家药监局药审中心. 国家药监局药审中心关于发布《罕见病酶替代疗法药物非临床研究指导原则(试行)》的通告(2024年第17号)[EB/OL]. (2024-02-23) [2024-08-02]. https://www.cde.org.cn/main/news/viewInfoCommon/ae3f90280fab5c58f928728816ede70c.
[30]
翟取, 苗采烈, 汤涵, 等. 我国零售药店执业药师药学服务能力自我评价调查研究[J]. 中国食品药品监管, 2024, (1): 98-108.
[31]
国家医保局官方公众号. “国谈药”配备机构查询[EB/OL]. (2023-09-07) [2024-08-02]. https://wx.nhsa.gov.cn/?code=081VNe000lnrRS19wa100US3pZ0VNe0j&state=weichat#/pages/negotiatingDrugs/negotiatingDrugs.
[32]
何阿妹, 徐源, 宋捷, 等. 国家医保谈判药物中罕见病用药落地情况分析——以20种罕见病用药为例[J]. 中国医疗保险, 2023, (9): 18-26.
[33]
中国政府网. 关于印发罕见病目录制订工作程序的通知[EB/OL]. (2018-06-05) [2024-06-25]. http://www.nhc.gov.cn/yzygj/s7659/201806/927defed71934ec8b032ccfca0afe0fb.shtml.
[34]
刘小龙, 练东玲, 吴健. 进行性骨化性纤维发育不良1例报告[J]. 中国实用内科杂志, 2021, 41(3): 261-264.
[35]
包和婧, 朱立新, 杨联军, 等. 我国进行性骨化性肌炎104例文献分析[J]. 分子影像学杂志, 2015, 38(4): 365-368.
[36]
张皖晋, 卓阳, 孙搏. 欧美罕见病药物研发的监管机制分析及启示[J]. 中国新药与临床杂志, 2023, 42(2): 85-90.
[37]
中国政府网. 关于罕见病药品增值税政策的通知[财税(2019)24号][EB/OL]. (2019-10-15) [2024-06-28]. https://www.gov.cn/zhengce/zhengceku/2019-10/15/content_5439874.htm.
[38]
中国政府网. 国务院关税税则委员会决定调整进境物品进口税[EB/OL]. (2019-04-08) [2024-09-18]. https://www.gov.cn/xinwen/2019-04/08/content_5380553.htm.
[39]
陈昕, 熊潇磊, 龚时薇. 中美政府资助罕见病与罕用药科研基金项目的比较分析[J]. 中国医院药学杂志, 2016, 36(12): 961-963.
[40]
Boat T F, Field M J. Rare diseases and orphan products: accelerating research and development[M]. Washington Dc: National Academies Press, 2011.
[41]
张抒扬, 董咚. 2020中国罕见病综合社会调研[R]. 中国罕见病联盟: 北京.
2024年第45卷第11期
17
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.11.002
  • 接收时间:2024-08-02
  • 首发时间:2026-11-17
  • 出版时间:2024-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-08-02
基金
作者信息
    1.中国药科大学国际医药商学院,江苏 南京 211198
    2.中国药科大学医药市场准入政策研究中心,江苏 南京 211198

通讯作者:

丁锦希,二级教授,博士生导师,研究方向:医药政策法规、医药市场准入与药物经济学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.11.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏